Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China flag China · Delayed Price · Currency is CNY
18.10
-0.20 (-1.09%)
Sep 2, 2026, 3:04 PM CST

SHE:003020 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Dec '23 Jan '23 Dec '21
Cash & Equivalents
226.88413.89439.69502.93642.58654.25
Short-Term Investments
--10.67---
Trading Asset Securities
325.5840.275861.520.120.13
Cash & Short-Term Investments
552.46454.16508.36564.45642.7654.39
Cash Growth
27.96%-10.66%-9.94%-12.17%-1.79%-14.64%
Accounts Receivable
396.97487.5415.63295.19321.02318.37
Other Receivables
5.784.628.0819.9736.036.08
Receivables
402.76492.12423.7315.16357.05324.45
Inventory
249.19204.5220.48242.91361.76188.86
Prepaid Expenses
-7.261.411.11--
Other Current Assets
32.1618.1931.5427.5191.0351.95
Total Current Assets
1,2371,1761,1851,1511,4531,220
Property, Plant & Equipment
975.99985.66972.75898.62538.12299.03
Long-Term Investments
168.37196.77194.11180.3914.420.71
Goodwill
74.4474.4474.4474.44--
Other Intangible Assets
94.197.61105.24113.2983.3889.51
Long-Term Deferred Tax Assets
17.3215.8114.5116.138.585.86
Long-Term Deferred Charges
6.023.866.947.417.618.8
Other Long-Term Assets
41.7735.4332.4942.2616.7630.9
Total Assets
2,6152,5862,5862,4842,1211,674

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Dec '23 Jan '23 Dec '21
Accounts Payable
340.71349.46347.53301.25460.66242.93
Accrued Expenses
23.1360.8563.1953.9545.2550.5
Short-Term Debt
10505050.05--
Current Portion of Leases
-2.544.364.5410.03-
Current Income Taxes Payable
27.397.479.0815.5312.716.05
Current Unearned Revenue
9.337.5933.0833.0942.6214.69
Other Current Liabilities
93.5942.6874.7184.3251.3613.88
Total Current Liabilities
506.5520.58581.95542.73622.63328.05
Long-Term Debt
78.159.6459.6531.01--
Long-Term Leases
1.431.714.572.843.3824.58
Long-Term Unearned Revenue
42.2744.918.2820.1612.9813.24
Long-Term Deferred Tax Liabilities
6.627.368.9313.431.39-
Other Long-Term Liabilities
----1.164.66
Total Liabilities
634.92634.19673.38610.18641.53370.53

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Dec '23 Jan '23 Dec '21
Common Stock
228.22190.18191.57159.68122.4792.64
Additional Paid-In Capital
472.01510.05518551.89554.93526.16
Retained Earnings
1,1401,1091,038994.95829.51685.11
Treasury Stock
---9.39-20.99-27.05-
Total Common Equity
1,8401,8091,7381,6861,4801,304
Minority Interest
139.57142.69174.71187.97--
Shareholders' Equity
1,9801,9521,9131,8731,4801,304
Total Liabilities & Equity
2,6152,5862,5862,4842,1211,674

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Dec '23 Jan '23 Dec '21
Total Debt
91.88113.9118.5888.4413.4124.58
Net Cash (Debt)
460.58340.27389.78476629.28629.8
Net Cash Growth
46.32%-12.70%-18.11%-24.36%-0.08%-17.84%
Net Cash Per Share
2.031.491.702.062.782.79
Filing Date Shares Outstanding
233.49228.22229.51229.93229.26225.45
Total Common Shares Outstanding
233.49228.22229.89229.93229.26225.45
Working Capital
730.06655.66603.54608.42829.92891.59
Book Value Per Share
7.887.937.567.336.465.78
Tangible Book Value
1,6721,6371,5581,4981,3961,214
Tangible Book Value Per Share
7.167.176.786.516.095.39
Buildings
-753.46547.66395.67140.12127.89
Machinery
-562.23480.99303.79174.84139.8
Construction In Progress
-51.66269.34459.66340.89130.35